The COVID-19 public health emergency (PHE) challenged hospital bed capacity severely limiting access to critical medical services in patients’ time of need. In response, the Centers for Medicare & Medicaid Services (CMS) collaborated with outside experts to develop what
- Blog
CMS Innovation Center’s One-Year Update on the Executive Order to Lower Prescription Drug Costs for Americans
This October marks one year since President Biden issued Executive Order 14087 “Lowering Prescription Drug Costs for Americans,” which complements the historic provisions in the Inflation Reduction Act that lower prescription drug costs. The Secretary of Health and Human Services, in response to the order, delivered a report to the White House outlining three selected models aimed at improving prescription drug affordability and access for people with Medicare and Medicaid: the Medicare $2 Drug List Model; the Cell and Gene Therapy Access Model; and the Accelerating Clinical Evidence Model Read more about CMS Innovation Center’s One-Year Update on the Executive Order to Lower Prescription Drug Costs for Americans